This literature review explores the global mental health crisis, focusing on major depressive disorder (MDD) and critiquing conventional treatments like SSRIs. It highlights psilocybin as a promising alternative, discussing its historical context, FDA recognition, clinical evidence, and potential benefits over traditional antidepressants, while also addressing research obstacles.
